<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01626989</url>
  </required_header>
  <id_info>
    <org_study_id>ST-1007-ASV4-MS</org_study_id>
    <nct_id>NCT01626989</nct_id>
  </id_info>
  <brief_title>Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With Sleep Disorders</brief_title>
  <official_title>Evaluation of the Philips Respironics BiPAP autoSV Devices in Subjects With</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philips Respironics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philips Respironics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparing two BiPAP autoSV devices in participants with complex sleep apnea and determining
      if the new device will treat those participants no worse than when compared to its
      predecessor device.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The use of the BiPAP autoSV4 device in participants with Complex Sleep Apnea Syndrome will
      treat those participants no worse than when compared to its predecessor device, the BiPAP
      autoSV Advanced™, with respect to:

      • Apnea-Hypopnea Index (AHI)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea-Hypopnea Index (AHI)</measure>
    <time_frame>up to 24 months</time_frame>
    <description>AHI will be determined will be determined across each PSG night</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>REM, NREM and Total Sleep Time (TST) Indices</measure>
    <time_frame>up to 24 months</time_frame>
    <description>REM, NREM and Total Sleep Time (TST) Indices</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central Apnea Index(CAI)</measure>
    <time_frame>up to 24 months</time_frame>
    <description>Central Apnea Index(CAI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Obstructive Apnea Index (OAI)</measure>
    <time_frame>up to 24 months</time_frame>
    <description>Obstructive Apnea Index (OAI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mixed Apnea Index (MAI)</measure>
    <time_frame>up to 24 months</time_frame>
    <description>Mixed Apnea Index (MAI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Onset Latency (SOL)</measure>
    <time_frame>up to 24 months</time_frame>
    <description>Sleep Onset Latency (SOL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>REM Onset Latency (ROL)</measure>
    <time_frame>up to 24 months</time_frame>
    <description>REM Onset Latency (ROL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wake After Sleep Onset (WASO)</measure>
    <time_frame>up to 24 months</time_frame>
    <description>Wake After Sleep Onset (WASO)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Sleep Time (TST)</measure>
    <time_frame>up to 24 months</time_frame>
    <description>Total Sleep Time (TST)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Efficiency (SE %)</measure>
    <time_frame>up to 24 months</time_frame>
    <description>Sleep Efficiency (SE %)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wake (W), Stages N1,N2,N3 (NREM), and REM (R) sleep (% TST)</measure>
    <time_frame>up to 24 months</time_frame>
    <description>Wake (W), Stages N1,N2,N3 (NREM), and REM (R) sleep (% TST)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal Index [total, AH-related, PLM-related, 'spontaneous']</measure>
    <time_frame>up to 24 months</time_frame>
    <description>Arousal Index [total, AH-related, PLM-related, 'spontaneous']</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nocturnal oxygenation (measured by continuous pulse oximetry during sleep study)</measure>
    <time_frame>up to 24 months</time_frame>
    <description>Nocturnal oxygenation (measured by continuous pulse oximetry during sleep study)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypopnea Index (HI)</measure>
    <time_frame>up to 24 months</time_frame>
    <description>Hypopnea Index (HI)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Sleep Disordered Breathing</condition>
  <condition>Sleep Apnea, Central</condition>
  <arm_group>
    <arm_group_label>BiPAP auto SV Advanced</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>BiPAP auto SV Advanced</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BiPAP auto SV 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Auto Servo Ventilation Device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BiPAP auto Advanced</intervention_name>
    <description>Auto Servo Ventilation Device</description>
    <arm_group_label>BiPAP auto SV Advanced</arm_group_label>
    <other_name>BiPAP Auto SV</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BiPAP auto SV4</intervention_name>
    <description>Auto Servo Ventilation Device</description>
    <arm_group_label>BiPAP auto SV 4</arm_group_label>
    <other_name>BiPAP Auto SV</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 21-80

          -  Ability to provide consent

          -  Documentation of medical stability by investigator

          -  Subjects who currently have been on PAP therapy for ≥ 4 weeks and who previously had a
             CPAP titration with CAI ≥ 5.

        OR Subjects who currently have been on PAP therapy for ≥ 4 weeks and who had a diagnostic
        study done, with a CAI ≥ 5, and were prescribed PAP therapy without a CPAP titration.

          -  Agreement to undergo a full-night, in-lab research CPAP Titration

          -  Agreement to undergo two full-night, in-lab therapy research PSG on BiPAP autoSV
             devices

        Exclusion Criteria:

          -  Major medical or psychiatric condition that would interfere with the demands of the
             study, adherence to positive airway pressure, or the ability to complete the study.
             For example, unstable congestive heart failure, chronic lung disease, neuromuscular
             disease, daytime hypercapnia, cancer, or renal failure.

          -  Systolic blood pressure &lt; 80 mm Hg at Baseline Visit.

          -  Participants in whom PAP therapy is otherwise medically contraindicated.

          -  Participants who are unwilling to wear CPAP

          -  Currently prescribed oxygen therapy (as needed, nocturnal, or continuous

          -  Participants with previously diagnosed respiratory failure or respiratory
             insufficiency and who are known to have chronically elevated arterial carbon dioxide
             levels while awake (PaCO2 ≥ 45mmHg).

          -  Participants who have had surgery of the upper airway, nose, sinus, or middle ear
             within the previous 90 days.

          -  Participants with untreated, non-OSA/CSA sleep disorders, including but not limited
             to; insomnia, periodic limb movement syndrome, or restless legs syndrome (PLM Arousal
             Index &gt; 15).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shahrokh Javaheri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sleepcare Diagnostics</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paul Wylie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arkansas Center for Sleep Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Goetting, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sleep Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Arkansas Center for Sleep Medicine</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleep Health</name>
      <address>
        <city>Portage</city>
        <state>Michigan</state>
        <zip>49024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleepcare Diagnostics</name>
      <address>
        <city>Mason</city>
        <state>Ohio</state>
        <zip>45040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2011</study_first_submitted>
  <study_first_submitted_qc>June 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2012</study_first_posted>
  <last_update_submitted>June 20, 2012</last_update_submitted>
  <last_update_submitted_qc>June 20, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea, Central</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

